[PHARMA] YoY Annualized Quarter Result on 30-Jun-2008 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
14-Aug-2008
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2008
Quarter
30-Jun-2008 [#2]
Profit Trend
QoQ- -14.66%
YoY- 149.05%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 CAGR
Revenue 1,563,526 1,335,790 1,293,856 1,326,230 1,112,932 1,003,774 941,312 8.82%
PBT 82,344 65,516 89,042 96,924 44,822 34,354 65,122 3.98%
Tax -23,056 -17,862 -22,610 -32,046 -17,402 -10,728 -22,940 0.08%
NP 59,288 47,654 66,432 64,878 27,420 23,626 42,182 5.83%
-
NP to SH 58,808 48,108 64,438 63,304 25,418 21,870 38,820 7.16%
-
Tax Rate 28.00% 27.26% 25.39% 33.06% 38.82% 31.23% 35.23% -
Total Cost 1,504,238 1,288,136 1,227,424 1,261,352 1,085,512 980,148 899,130 8.95%
-
Net Worth 451,381 417,306 400,063 362,623 314,515 316,549 256,416 9.87%
Dividend
30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 CAGR
Div - 100,581 57,763 38,508 32,093 24,596 21,453 -
Div Payout % - 209.07% 89.64% 60.83% 126.26% 112.47% 55.26% -
Equity
30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 CAGR
Net Worth 451,381 417,306 400,063 362,623 314,515 316,549 256,416 9.87%
NOSH 106,962 107,001 106,968 106,968 106,978 106,942 102,157 0.76%
Ratio Analysis
30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 CAGR
NP Margin 3.79% 3.57% 5.13% 4.89% 2.46% 2.35% 4.48% -
ROE 13.03% 11.53% 16.11% 17.46% 8.08% 6.91% 15.14% -
Per Share
30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 CAGR
RPS 1,461.75 1,248.38 1,209.56 1,239.83 1,040.34 938.61 921.43 7.99%
EPS 54.98 44.96 60.24 59.18 23.76 20.44 38.00 6.34%
DPS 0.00 94.00 54.00 36.00 30.00 23.00 21.00 -
NAPS 4.22 3.90 3.74 3.39 2.94 2.96 2.51 9.04%
Adjusted Per Share Value based on latest NOSH - 106,995
30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 CAGR
RPS 108.49 92.68 89.77 92.02 77.22 69.65 65.31 8.82%
EPS 4.08 3.34 4.47 4.39 1.76 1.52 2.69 7.18%
DPS 0.00 6.98 4.01 2.67 2.23 1.71 1.49 -
NAPS 0.3132 0.2895 0.2776 0.2516 0.2182 0.2196 0.1779 9.88%
Price Multiplier on Financial Quarter End Date
30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 CAGR
Date 30/06/11 30/06/10 30/06/09 30/06/08 29/06/07 30/06/06 30/06/05 -
Price 5.90 4.98 3.80 3.27 3.53 4.51 4.53 -
P/RPS 0.40 0.40 0.31 0.26 0.34 0.48 0.49 -3.32%
P/EPS 10.73 11.08 6.31 5.53 14.86 22.05 11.92 -1.73%
EY 9.32 9.03 15.85 18.10 6.73 4.53 8.39 1.76%
DY 0.00 18.88 14.21 11.01 8.50 5.10 4.64 -
P/NAPS 1.40 1.28 1.02 0.96 1.20 1.52 1.80 -4.10%
Price Multiplier on Announcement Date
30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 30/06/05 CAGR
Date 10/08/11 11/08/10 21/08/09 14/08/08 17/08/07 16/08/06 18/08/05 -
Price 5.90 4.95 4.00 3.44 3.44 4.00 5.00 -
P/RPS 0.40 0.40 0.33 0.28 0.33 0.43 0.54 -4.87%
P/EPS 10.73 11.01 6.64 5.81 14.48 19.56 13.16 -3.34%
EY 9.32 9.08 15.06 17.20 6.91 5.11 7.60 3.45%
DY 0.00 18.99 13.50 10.47 8.72 5.75 4.20 -
P/NAPS 1.40 1.27 1.07 1.01 1.17 1.35 1.99 -5.69%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment